That's a shame as I was hoping they would report RDM's stand...

That's a shame as I was hoping they would report RDM's stand alone cash statements in the quarterly at some point, as RDM itself operates a very lean operation quarter to quarter. Consolidating the accounts makes it look like RDM burns $2m+ a quarter on first glance. If MMA do a cap raise and issue the typical 10% dilution, that should get RDM just below 50% holding.

I really hope RDM will sell down MMA shares at some stage so we don't need to cap raise to drill out and test Sybella (pending successful met testwork), but I somewhat doubt it with Rob being on the board of MMA and being involved in its development since the beginning. The value of MMA shares could get Sybella to FID, plus do some drill testing of their other targets in the portfolio. If an investor wanted to get in on MMA, they could buy MMA directly surely?